170
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?

ORCID Icon, , , & ORCID Icon
Pages 3589-3599 | Received 29 Jun 2022, Accepted 28 Sep 2022, Published online: 18 Nov 2022

Figures & data

Table 1 The Characteristics of the Investigated T2D Patients (the Results are Expressed as Median and Interquartile Range)

Figure 1 Relative frequency of the microbial population at the orders level in all investigated T2DM patients.

Figure 1 Relative frequency of the microbial population at the orders level in all investigated T2DM patients.

Figure 2 Percentages of the microbial population at the orders level of Metfromin group of T2DM patients.

Figure 2 Percentages of the microbial population at the orders level of Metfromin group of T2DM patients.

Figure 3 Percentages of the microbial population at the orders level of Metformin+Insulin group of T2DM patients.

Figure 3 Percentages of the microbial population at the orders level of Metformin+Insulin group of T2DM patients.

Figure 4 Percentages of the microbial population at the orders level of Metformin group of T2DM patients – The 1% from the other bacterial orders.

Figure 4 Percentages of the microbial population at the orders level of Metformin group of T2DM patients – The 1% from the other bacterial orders.

Figure 5 Percentages of the microbial population at the orders level of Metformin+Insulin group of T2DM patients – The 1% from the other bacterial orders.

Figure 5 Percentages of the microbial population at the orders level of Metformin+Insulin group of T2DM patients – The 1% from the other bacterial orders.

Figure 6 Shannon diversity of microbiome in investigated groups.

Figure 6 Shannon diversity of microbiome in investigated groups.